Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight-loss ...

The best memoirs and biographies blend fascinating anecdotes with deeper meditations that make us reflect on our own lives. From poignant coming-of-age tales to candid confessionals, these are our top ...

OpenAI unveils Aardvark, an autonomous AI agent for scalable vulnerability detection and patching Aardvark mimics human researchers: reads code, runs tests, and proposes targeted security fixes In ...

SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...

OpenAI has introduced Aardvark, an AI-powered security researcher tool. Built on its flagship GPT-5 model, the system is designed to help developers and security teams explore vulnerabilities in ...

In today’s digital world, software security is one of the biggest challenges for companies and developers. Every year, thousands of new security flaws, known as vulnerabilities, are discovered in ...

Currently in private beta, the GPT-5-powered security agent scans, reasons, and patches software like a real researcher, aiming to embed AI-driven defense into the development workflow. OpenAI has ...

In a digital era where software vulnerabilities can topple companies and compromise entire infrastructures overnight, OpenAI’s latest experiment takes aim at one of technology’s oldest weaknesses: ...

OpenAI (OPENAI) has released a private beta version of Aardvark, a security research agent that autonomously monitors code to identify and help fix vulnerabilities in software. "Aardvark represents a ...